Isovaleric acidemia

Treatment

Is there a treatment for Isovaleric Acidemia?

Isovaleric Acidemia is usually treated by a low protein diet and a supplement called L-carnitine. In addition, people with Isovaleric Acidemia need to have a diet that is low in the protein building block called leucine. People with Isovaleric Acidemia may also benefit from having a supplement of the protein building block glycine. It is important to make sure you are being treated by a team of doctors and dieticians that are used to treating conditions like Isovaleric Acidemia. The Organic Acidemia Association has a tool on their website to help you find metabolic clinics close to you that are familiar with Isovaleric Acidemia.

References
  • http://rarediseases.org/rare-diseases/acidemia-isovaleric/
  • http://www.omim.org/entry/243500
Show More Content Like This

More Treatment Content

Are there other symptom specific treatments for Isovaleric Acidemia?

Are there other symptom specific treatments for Isovaleric Acidemia?

Other than eating a low protein diet and restricting a protein building block called leucine, people with Isovaleric Acidemia can increase their growth and increase their chances of normal development by taking a supplement of the protein building block called glycine. Another important treatment is to take carnitine which can help break down and clear away abnormal substances in the bodies of people with Isovaleric Acidemia. Check with the Organic Acidemia Association to help find metabolic clinics close to you where you can be treated for Isovaleric Acidemia. It is likely that over time as we learn more about IVA, new recommendations for treatment may become available. It will be important to follow up with your genetics specialist regularly to learn about new developments in the treatment of IVA.

References
  • http://rarediseases.org/rare-diseases/acidemia-isovaleric/
  • http://www.omim.org/entry/243500

We use cookies to ensure that we give you the best experience on our website. By continuing to browse this site, you are agreeing to our use of cookies.

Continue Find out more about our use of cookies and similar technology

This content comes from a hidden element on this page.

The inline option preserves bound JavaScript events and changes, and it puts the content back where it came from when it is closed.

Remember Me